# Protalix BioTherapeutics, Inc.: Form 8-K, filed Nov 16, 2015

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2015-11-16
- Accepted by EDGAR: Nov 16, 2015, 07:14 ET
- Period: 2015-11-16
- Accession: 0001144204-15-065519
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420415065519/v424821_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420415065519/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420415065519/v424821_8k.htm

Filed Nov 16, 2015.
Source: SEC EDGAR, the filing index for accession 0001144204-15-065519. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
